| Literature DB >> 27040688 |
Adriana P Rebelo1, Alexander J Abrams1, Ellen Cottenie2, Alejandro Horga2, Michael Gonzalez1, Dana M Bis1, Avencia Sanchez-Mejias1, Milena Pinto1, Elena Buglo1, Kasey Markel3, Jeffrey Prince3, Matilde Laura2, Henry Houlden4, Julian Blake5, Cathy Woodward2, Mary G Sweeney6, Janice L Holton2, Michael Hanna2, Julia E Dallman3, Michaela Auer-Grumbach7, Mary M Reilly2, Stephan Zuchner8.
Abstract
Abnormal protein aggregation is observed in an expanding number of neurodegenerative diseases. Here, we describe a mechanism for intracellular toxic protein aggregation induced by an unusual mutation event in families affected by axonal neuropathy. These families carry distinct frameshift variants in NEFH (neurofilament heavy), leading to a loss of the terminating codon and translation of the 3' UTR into an extra 40 amino acids. In silico aggregation prediction suggested the terminal 20 residues of the altered NEFH to be amyloidogenic, which we confirmed experimentally by serial deletion analysis. The presence of this amyloidogenic motif fused to NEFH caused prominent and toxic protein aggregates in transfected cells and disrupted motor neurons in zebrafish. We identified a similar aggregation-inducing mechanism in NEFL (neurofilament light) and FUS (fused in sarcoma), in which mutations are known to cause aggregation in Charcot-Marie-Tooth disease and amyotrophic lateral sclerosis, respectively. In summary, we present a protein-aggregation-triggering mechanism that should be taken into consideration during the evaluation of stop-loss variants.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27040688 PMCID: PMC4833435 DOI: 10.1016/j.ajhg.2016.02.022
Source DB: PubMed Journal: Am J Hum Genet ISSN: 0002-9297 Impact factor: 11.025